Improved Risk Prediction in DLBCL By Combining Clinical and PET Features with Interim PET Assessment

被引：0

作者：

Hanoun, Christine ^{[1
]}

Heymans, Martijn ^{[2
]}

Wiegers, Sanne ^{[3
]}

Bes, Annelies ^{[4
]}

Duehrsen, Ulrich ^{[5
]}

Huettmann, Andreas ^{[1
]}

Kurch, Lars ^{[6
]}

Barrington, Sally F. ^{[7
,8
]}

Mikhaeel, George ^{[9
,10
]}

Lugtenburg, Pieternella ^{[11
]}

Ceriani, Luca ^{[12
]}

Zucca, Emanuele ^{[13
,14
]}

Gyorke, Tamas ^{[15
]}

Czibor, Sandor ^{[16
]}

Zwezerijnen, Gerben ^{[17
]}

Boellaard, Ronald ^{[18
]}

Zijlstra, Josee M. ^{[19
]}

Eertink, Corinne ^{[20
]}

机构：

[1] Uniklinikum Essen, Hematol, Essen, Germany

[2] Amsterdam UMC, Locat Vumc, Amsterdam, Netherlands

[3] Vrije Univ Amsterdam, Amsterdam UMC, Dept Hematol, Canc Ce, Amsterdam, Netherlands

[4] Amsterdam UMC, Hematol, Amsterdam, Netherlands

[5] Univ Klinikum Essen, Essen, Germany

[6] Univ Hosp Leipzig, Leipzig, Germany

[7] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England

[8] Guys & St Thomas PET Ctr, London, England

[9] Guys & St Thomas NHS Trust, Guys Canc Ctr, London, England

[10] Kings Coll Univ, London, England

[11] Erasmus MC Univ Med Ctr Rotterdam, Rotterdam, Netherlands

[12] Imaging Inst Southern Switzerland IIMSI, Lugano, Switzerland

[13] IOSI Oncol Inst Southern Switzerland, Lodrino, Switzerland

[14] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[15] Semmelweis Egyet, Budapest, Hungary

[16] Semmelweis Univ, Dept Nucl Med, Med Imaging Ctr, Budapest, Hungary

[17] Amsterdam UMC Radiol & Nucl Med, Canc Ctr Amsterdam, Amsterdam, Netherlands

[18] Vrije Univ Amsterdam, Amsterdam UMC, Dept Radiol & Nucl, Amsterdam, Netherlands

[19] Canc Ctr Amsterdam, Imaging, Amsterdam, Netherlands

[20] Canc Ctr Amsterdam, Amsterdam, Netherlands

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190277

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Diagnostic Value of FDG PET/CT in Assessment of Bone Marrow Infiltration in DLBCL
Doma, A.
Novakovic, B. Jezersek
Zagar, I.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S560 - S560
[32] Are the Deauville criteria a reliable tool for assessment of interim PET in Hodgkin lymphoma ?
Barrington, S. F.
Kostakoglu, L.
Hutchings, M.
Meignan, M.
Biggi, A.
Gregianin, M.
Chauvie, S.
Gallamini, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S164 - S164
[33] The role of PET for interim response assessment in patients with Hodgkin's lymphoma
Zaucha, Jan
Danielewicz, Iwona
Malkowski, Bogdan
Zaucha, Renata
Lesniewski-Kmak, Krzysztof
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2009, 13 (04): : 161 - 166
[34] Integrating respiratory gating into PET/CT and PET/MR: evaluating an improved clinical workflow
Solari, E.
Kruschke, C.
Schachoff, S.
Bogdanovic, B.
Winter, A.
Mustafa, M.
Weber, W.
Nekolla, S. G.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S354 - S355
[35] Validation of high-risk CT & PET features for prediction of local recurrence after SBRT
Wagner, K.
Adebahr, S.
Gkika, E.
Brunner, T.
Ruf, J.
Rischke, H.
Grosu, A.
Vach, W.
Nestle, U.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S179 - S179
[36] Efficacy of early DLBCL treatment assessment using FLT PET/CT - Initial results
Malkowski, Bogdan
Chmielowska, Ewa
Olejniczak, Monika
Makarewicz, Adrianna
Pietrzak, Tomasz
Kasprzak, Krzysztof
Kachniarz, Artur
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[37] Prognostic Value of Interim PET/CT in Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL). Experience of the Spanish Geltamo Group
Coronado, Monica
Pardal, Emilia
Couto, Rosa
de la Cruz, Fatima
Panizo, Carlos
Grande, Carlos
Arranz, Reyes
Jose Ramirez, Maria
Hernandez, Roberto
Martin, Alejandro
Caballero, Dolores
BLOOD, 2012, 120 (21)
[38] Role of Interim and End of treatment PET/CT for Response Assessment and Prediction of Relapse in Post-transplant Lymphoproliferative Disorder
Van Keerberghen, C.
Vergote, V.
Goffin, K.
Verhoef, G.
Tousseyn, T.
Dierickx, D.
Gheysens, O.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S440 - S441
[39] RISK-ADAPTED THERAPY USING BIOPSY CONFIRMATION OF ABNORMAL INTERIM FDG-PET FOR PATIENTS WITH ADVANCED STAGE DIFFUSE LARGE B CELL LYMPHOMA (DLBCL), AND EXPLORATORY EVALUATION OF FLT-PET
Moskowitz, C. H.
Schoder, H.
Hamlin, P. A.
Gerecitano, J. F.
Horwitz, S. M.
Matasar, M. J.
Moskowitz, A. J.
Noy, A.
Palomba, M.
Portlock, C. S.
Straus, D. J.
Graustein, T. A.
Teruya-Feldstein, J.
Zelenetz, A. D.
ANNALS OF ONCOLOGY, 2011, 22 : 158 - 158
[40] Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer
Moore, Richard G.
Hawkins, Douglas M.
Miller, M. Craig
Landrum, Lisa M.
Gajewski, Walter
Ball, John J.
Allard, W. Jeffery
Skates, Steven J.
GYNECOLOGIC ONCOLOGY, 2014, 135 (03) : 547 - 551

← 1 2 3 4 5 →